世界の速効型インスリン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rapid Acting Insulins Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4792 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、速効型インスリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リスプロ、アスパルト（ノボログ）、グルリジン（アピドラ））、用途別市場規模（1型糖尿病、2型糖尿病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・速効型インスリンの市場動向 ・企業の競争状況、市場シェア ・速効型インスリンの種類別市場規模と予測2016-2027（リスプロ、アスパルト（ノボログ）、グルリジン（アピドラ）） ・速効型インスリンの用途別市場規模と予測2016-2027（1型糖尿病、2型糖尿病） ・速効型インスリンの北米市場規模2016-2027（アメリカ、カナダ） ・速効型インスリンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・速効型インスリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・速効型インスリンの中南米市場規模2016-2027（メキシコ、ブラジル） ・速効型インスリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Novo Nordisk、Sanofi） ・結論

Rapid Acting Insulins are usually taken before or with a meal. They act very quickly to minimise the rise in blood sugar which follows eating. Rapid acting insulins can be used for both type 1 and type 2 diabetes, injected or delivered via an insulin pump.

Market Analysis and Insights: Global Rapid Acting Insulins Market
The global Rapid Acting Insulins market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rapid Acting Insulins market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rapid Acting Insulins market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rapid Acting Insulins market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rapid Acting Insulins market.

Global Rapid Acting Insulins Scope and Market Size
Rapid Acting Insulins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Acting Insulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Lispro
Aspart (NovoLog)
Glulisine (Apidra)

Segment by Application
Type 1 Diabetes
Type 2 Diabetes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Novo Nordisk
Sanofi

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rapid Acting Insulins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lispro
1.2.3 Aspart (NovoLog)
1.2.4 Glulisine (Apidra)
1.3 Market by Application
1.3.1 Global Rapid Acting Insulins Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rapid Acting Insulins Market Perspective (2016-2027)
2.2 Rapid Acting Insulins Growth Trends by Regions
2.2.1 Rapid Acting Insulins Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rapid Acting Insulins Historic Market Share by Regions (2016-2021)
2.2.3 Rapid Acting Insulins Forecasted Market Size by Regions (2022-2027)
2.3 Rapid Acting Insulins Industry Dynamic
2.3.1 Rapid Acting Insulins Market Trends
2.3.2 Rapid Acting Insulins Market Drivers
2.3.3 Rapid Acting Insulins Market Challenges
2.3.4 Rapid Acting Insulins Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rapid Acting Insulins Players by Revenue
3.1.1 Global Top Rapid Acting Insulins Players by Revenue (2016-2021)
3.1.2 Global Rapid Acting Insulins Revenue Market Share by Players (2016-2021)
3.2 Global Rapid Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rapid Acting Insulins Revenue
3.4 Global Rapid Acting Insulins Market Concentration Ratio
3.4.1 Global Rapid Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rapid Acting Insulins Revenue in 2020
3.5 Rapid Acting Insulins Key Players Head office and Area Served
3.6 Key Players Rapid Acting Insulins Product Solution and Service
3.7 Date of Enter into Rapid Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rapid Acting Insulins Breakdown Data by Type
4.1 Global Rapid Acting Insulins Historic Market Size by Type (2016-2021)
4.2 Global Rapid Acting Insulins Forecasted Market Size by Type (2022-2027)

5 Rapid Acting Insulins Breakdown Data by Application
5.1 Global Rapid Acting Insulins Historic Market Size by Application (2016-2021)
5.2 Global Rapid Acting Insulins Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rapid Acting Insulins Market Size (2016-2027)
6.2 North America Rapid Acting Insulins Market Size by Type
6.2.1 North America Rapid Acting Insulins Market Size by Type (2016-2021)
6.2.2 North America Rapid Acting Insulins Market Size by Type (2022-2027)
6.2.3 North America Rapid Acting Insulins Market Size by Type (2016-2027)
6.3 North America Rapid Acting Insulins Market Size by Application
6.3.1 North America Rapid Acting Insulins Market Size by Application (2016-2021)
6.3.2 North America Rapid Acting Insulins Market Size by Application (2022-2027)
6.3.3 North America Rapid Acting Insulins Market Size by Application (2016-2027)
6.4 North America Rapid Acting Insulins Market Size by Country
6.4.1 North America Rapid Acting Insulins Market Size by Country (2016-2021)
6.4.2 North America Rapid Acting Insulins Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rapid Acting Insulins Market Size (2016-2027)
7.2 Europe Rapid Acting Insulins Market Size by Type
7.2.1 Europe Rapid Acting Insulins Market Size by Type (2016-2021)
7.2.2 Europe Rapid Acting Insulins Market Size by Type (2022-2027)
7.2.3 Europe Rapid Acting Insulins Market Size by Type (2016-2027)
7.3 Europe Rapid Acting Insulins Market Size by Application
7.3.1 Europe Rapid Acting Insulins Market Size by Application (2016-2021)
7.3.2 Europe Rapid Acting Insulins Market Size by Application (2022-2027)
7.3.3 Europe Rapid Acting Insulins Market Size by Application (2016-2027)
7.4 Europe Rapid Acting Insulins Market Size by Country
7.4.1 Europe Rapid Acting Insulins Market Size by Country (2016-2021)
7.4.2 Europe Rapid Acting Insulins Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rapid Acting Insulins Market Size (2016-2027)
8.2 Asia-Pacific Rapid Acting Insulins Market Size by Type
8.2.1 Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rapid Acting Insulins Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2027)
8.3 Asia-Pacific Rapid Acting Insulins Market Size by Application
8.3.1 Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rapid Acting Insulins Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2027)
8.4 Asia-Pacific Rapid Acting Insulins Market Size by Region
8.4.1 Asia-Pacific Rapid Acting Insulins Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rapid Acting Insulins Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rapid Acting Insulins Market Size (2016-2027)
9.2 Latin America Rapid Acting Insulins Market Size by Type
9.2.1 Latin America Rapid Acting Insulins Market Size by Type (2016-2021)
9.2.2 Latin America Rapid Acting Insulins Market Size by Type (2022-2027)
9.2.3 Latin America Rapid Acting Insulins Market Size by Type (2016-2027)
9.3 Latin America Rapid Acting Insulins Market Size by Application
9.3.1 Latin America Rapid Acting Insulins Market Size by Application (2016-2021)
9.3.2 Latin America Rapid Acting Insulins Market Size by Application (2022-2027)
9.3.3 Latin America Rapid Acting Insulins Market Size by Application (2016-2027)
9.4 Latin America Rapid Acting Insulins Market Size by Country
9.4.1 Latin America Rapid Acting Insulins Market Size by Country (2016-2021)
9.4.2 Latin America Rapid Acting Insulins Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rapid Acting Insulins Market Size (2016-2027)
10.2 Middle East & Africa Rapid Acting Insulins Market Size by Type
10.2.1 Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rapid Acting Insulins Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2027)
10.3 Middle East & Africa Rapid Acting Insulins Market Size by Application
10.3.1 Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rapid Acting Insulins Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2027)
10.4 Middle East & Africa Rapid Acting Insulins Market Size by Country
10.4.1 Middle East & Africa Rapid Acting Insulins Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rapid Acting Insulins Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Rapid Acting Insulins Introduction
11.1.4 Eli Lilly Revenue in Rapid Acting Insulins Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Rapid Acting Insulins Introduction
11.2.4 Novo Nordisk Revenue in Rapid Acting Insulins Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Rapid Acting Insulins Introduction
11.3.4 Sanofi Revenue in Rapid Acting Insulins Business (2016-2021)
11.3.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rapid Acting Insulins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Lispro
Table 3. Key Players of Aspart (NovoLog)
Table 4. Key Players of Glulisine (Apidra)
Table 5. Global Rapid Acting Insulins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rapid Acting Insulins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Rapid Acting Insulins Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Rapid Acting Insulins Market Share by Regions (2016-2021)
Table 9. Global Rapid Acting Insulins Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Rapid Acting Insulins Market Share by Regions (2022-2027)
Table 11. Rapid Acting Insulins Market Trends
Table 12. Rapid Acting Insulins Market Drivers
Table 13. Rapid Acting Insulins Market Challenges
Table 14. Rapid Acting Insulins Market Restraints
Table 15. Global Rapid Acting Insulins Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Rapid Acting Insulins Market Share by Players (2016-2021)
Table 17. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2020)
Table 18. Ranking of Global Top Rapid Acting Insulins Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Rapid Acting Insulins Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rapid Acting Insulins Product Solution and Service
Table 22. Date of Enter into Rapid Acting Insulins Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Rapid Acting Insulins Revenue Market Share by Type (2016-2021)
Table 26. Global Rapid Acting Insulins Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Rapid Acting Insulins Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Rapid Acting Insulins Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Rapid Acting Insulins Revenue Market Share by Application (2016-2021)
Table 30. Global Rapid Acting Insulins Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Rapid Acting Insulins Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Rapid Acting Insulins Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Rapid Acting Insulins Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Rapid Acting Insulins Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Rapid Acting Insulins Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Rapid Acting Insulins Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Rapid Acting Insulins Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Rapid Acting Insulins Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Rapid Acting Insulins Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly Company Details
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Rapid Acting Insulins Product
Table 65. Eli Lilly Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Novo Nordisk Company Details
Table 68. Novo Nordisk Business Overview
Table 69. Novo Nordisk Rapid Acting Insulins Product
Table 70. Novo Nordisk Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
Table 71. Novo Nordisk Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Rapid Acting Insulins Product
Table 75. Sanofi Revenue in Rapid Acting Insulins Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rapid Acting Insulins Market Share by Type: 2020 VS 2027
Figure 2. Lispro Features
Figure 3. Aspart (NovoLog) Features
Figure 4. Glulisine (Apidra) Features
Figure 5. Global Rapid Acting Insulins Market Share by Application: 2020 VS 2027
Figure 6. Type 1 Diabetes Case Studies
Figure 7. Type 2 Diabetes Case Studies
Figure 8. Rapid Acting Insulins Report Years Considered
Figure 9. Global Rapid Acting Insulins Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rapid Acting Insulins Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rapid Acting Insulins Market Share by Regions: 2020 VS 2027
Figure 12. Global Rapid Acting Insulins Market Share by Regions (2022-2027)
Figure 13. Global Rapid Acting Insulins Market Share by Players in 2020
Figure 14. Global Top Rapid Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rapid Acting Insulins as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rapid Acting Insulins Revenue in 2020
Figure 16. Global Rapid Acting Insulins Revenue Market Share by Type (2016-2021)
Figure 17. Global Rapid Acting Insulins Revenue Market Share by Type (2022-2027)
Figure 18. North America Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rapid Acting Insulins Market Share by Type (2016-2027)
Figure 20. North America Rapid Acting Insulins Market Share by Application (2016-2027)
Figure 21. North America Rapid Acting Insulins Market Share by Country (2016-2027)
Figure 22. United States Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rapid Acting Insulins Market Share by Type (2016-2027)
Figure 26. Europe Rapid Acting Insulins Market Share by Application (2016-2027)
Figure 27. Europe Rapid Acting Insulins Market Share by Country (2016-2027)
Figure 28. Germany Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rapid Acting Insulins Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rapid Acting Insulins Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rapid Acting Insulins Market Share by Region (2016-2027)
Figure 38. China Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rapid Acting Insulins Market Share by Type (2016-2027)
Figure 46. Latin America Rapid Acting Insulins Market Share by Application (2016-2027)
Figure 47. Latin America Rapid Acting Insulins Market Share by Country (2016-2027)
Figure 48. Mexico Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rapid Acting Insulins Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rapid Acting Insulins Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rapid Acting Insulins Market Share by Country (2016-2027)
Figure 54. Turkey Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rapid Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Eli Lilly Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
Figure 58. Novo Nordisk Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Rapid Acting Insulins Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---